Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People with breast cancer who have been referred for a specialist genetics consultation that includes broad genetic panel testing (covering BRCA1 and BRCA2 genes, among others) as part of their standard cancer care
- People who have received their breast cancer diagnosis within the last 6 months
- People who agree to follow all study procedures and complete questionnaires during or after their consultation
- People who are enrolled in the French social security system
Who may not be able to join:
- People with another condition or disorder that could make it difficult to understand the study information or complete the questionnaires
- People who do not have an email address, internet access, or a device to connect to the internet
- Women who are pregnant, possibly pregnant, or currently breastfeeding
- People who are under legal guardianship, curatorship, or are deprived of their liberty
- People for whom regular trial follow-up would not be possible due to geographical, social, or psychological reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 03.80.73.75.00
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Compare the results obtained with an ultra-rapid kit BRCA1/2 with those obtained with the current gold standard, by checking the sensitivity, specificity and the rate of patients correctly classified for BRCA1 and 2 status
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.